For parents by parents
Respiratory syncytial virus (RSV) is a highly contagious infection that causes similar symptoms as the common cold. However, it can develop into a severe respiratory illness such as bronchiolitis and pneumonia. RSV predominantly causes severe infection in children in the first year of life. Neonates born prematurely and/or with congenital conditions such as chronic heart and lung disease, or children with Down syndrome being at an increased risk for complications from this virus.
about RSV uitklapper, klik om te openen
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
highly contagious uitklapper, klik om te openen
RSV is highly contagious and can be spread through droplets containing the virus when someone coughs or sneezes. RSV can also can live on surfaces (such as countertops or doorknobs) and on hands and clothing, so it can be easily spread when a person touches something that is contaminated.
RSV therefore spreads rapidly through schools and childcare centers. Babies often get it when older siblings carry the virus home from school and pass it on to them. Most children have been infected with RSV at least once by the time they are 2 years old.
symptoms uitklapper, klik om te openen
In adults, RSV may only produce symptoms of a common cold, such as a stuffy or runny nose, sore throat, mild headache, cough, fever, and a general feeling of being ill.
In premature babies and children with diseases that affect the lungs, heart, or immune system, RSV infections can lead to other more serious illnesses.
symptoms uitklapper, klik om te openen
In adults, RSV may only produce symptoms of a common cold, such as a stuffy or runny nose, sore throat, mild headache, cough, fever, and a general feeling of being ill.
In premature babies and children with diseases that affect the lungs, heart, or immune system, RSV infections can lead to other more serious illnesses.
highly contagious uitklapper, klik om te openen
RSV is highly contagious and can be spread through droplets containing the virus when someone coughs or sneezes. RSV can also can live on surfaces (such as countertops or doorknobs) and on hands and clothing, so it can be easily spread when a person touches something that is contaminated.
RSV therefore spreads rapidly through schools and childcare centers. Babies often get it when older siblings carry the virus home from school and pass it on to them. Most children have been infected with RSV at least once by the time they are 2 years old.
epidemics uitklapper, klik om te openen
RSV infections often occur in epidemics that last from late fall through early spring and during the winter months in temperate countries or during the rainy season in tropical countries.
Respiratory illness caused by RSV — such as bronchiolitis or pneumonia — usually lasts about a week, but some cases may last several weeks
epidemics uitklapper, klik om te openen
RSV infections often occur in epidemics that last from late fall through early spring and during the winter months in temperate countries or during the rainy season in tropical countries.
Respiratory illness caused by RSV — such as bronchiolitis or pneumonia — usually lasts about a week, but some cases may last several weeks
diagnosis uitklapper, klik om te openen
Doctors typically diagnose RSV by taking a medical history and doing a physical exam. Generally, in healthy kids it is not necessary to distinguish RSV from a common cold. However, if a child has other health conditions, a doctor might want to make a specific diagnosis; in that case, RSV is identified in nasal secretions.
diagnosis uitklapper, klik om te openen
Doctors typically diagnose RSV by taking a medical history and doing a physical exam. Generally, in healthy kids it is not necessary to distinguish RSV from a common cold. However, if a child has other health conditions, a doctor might want to make a specific diagnosis; in that case, RSV is identified in nasal secretions.
treatment uitklapper, klik om te openen
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
prognosis uitklapper, klik om te openen
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
about RSV uitklapper, klik om te openen
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
In addition to severe/acute disease, links found between RSV infections indicate an increased risk in the development of asthma in later in life.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
RSV infection is the second leading cause of death during infancy, globally. Annual RSV related deaths have been estimated at 253.000, accounting for up to 6.7% of the mortality of children aged <1 year.
Of these deaths, 99% occur in developing countries.
highly contagious uitklapper, klik om te openen
RSV is highly contagious and can be spread through droplets containing the virus when someone coughs or sneezes. RSV can also can live on surfaces (such as countertops or doorknobs) and on hands and clothing, so it can be easily spread when a person touches something that is contaminated.
RSV therefore spreads rapidly through schools and childcare centers. Babies often get it when older siblings carry the virus home from school and pass it on to them. Most children have been infected with RSV at least once by the time they are 2 years old.
symptoms uitklapper, klik om te openen
In adults, RSV may only produce symptoms of a common cold, such as a stuffy or runny nose, sore throat, mild headache, cough, fever, and a general feeling of being ill.
In premature babies and children with diseases that affect the lungs, heart, or immune system, RSV infections can lead to other more serious illnesses.
symptoms uitklapper, klik om te openen
In adults, RSV may only produce symptoms of a common cold, such as a stuffy or runny nose, sore throat, mild headache, cough, fever, and a general feeling of being ill.
In premature babies and children with diseases that affect the lungs, heart, or immune system, RSV infections can lead to other more serious illnesses.
highly contagious uitklapper, klik om te openen
RSV is highly contagious and can be spread through droplets containing the virus when someone coughs or sneezes. RSV can also can live on surfaces (such as countertops or doorknobs) and on hands and clothing, so it can be easily spread when a person touches something that is contaminated.
RSV therefore spreads rapidly through schools and childcare centers. Babies often get it when older siblings carry the virus home from school and pass it on to them. Most children have been infected with RSV at least once by the time they are 2 years old.
epidemics uitklapper, klik om te openen
RSV infections often occur in epidemics that last from late fall through early spring and during the winter months in temperate countries or during the rainy season in tropical countries.
Respiratory illness caused by RSV — such as bronchiolitis or pneumonia — usually lasts about a week, but some cases may last several weeks
epidemics uitklapper, klik om te openen
RSV infections often occur in epidemics that last from late fall through early spring and during the winter months in temperate countries or during the rainy season in tropical countries.
Respiratory illness caused by RSV — such as bronchiolitis or pneumonia — usually lasts about a week, but some cases may last several weeks
diagnosis uitklapper, klik om te openen
Doctors typically diagnose RSV by taking a medical history and doing a physical exam. Generally, in healthy kids it is not necessary to distinguish RSV from a common cold. However, if a child has other health conditions, a doctor might want to make a specific diagnosis; in that case, RSV is identified in nasal secretions.
diagnosis uitklapper, klik om te openen
Doctors typically diagnose RSV by taking a medical history and doing a physical exam. Generally, in healthy kids it is not necessary to distinguish RSV from a common cold. However, if a child has other health conditions, a doctor might want to make a specific diagnosis; in that case, RSV is identified in nasal secretions.
treatment uitklapper, klik om te openen
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
Infants and children with a severe RSV infection may be admitted to a hospital. Treatment may include:
• Oxygen supplementation
• Fluids through a nasogastric tube or a vein (by IV)
• Respiratory support with noninvasive/invasive positive pressure
It is important to understand that these are therapies used in the management of the virus. Many other therapies have been shown to have limited or no benefit, including the use of broncho dilators and corticosteroids.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
There is no specific treatment for children with RSV infection. Antibiotics are not effective in treating RSV. Most mild to moderate infections generally resolve without treatment at home. However, close monitoring is important, especially in at-risk children (see Risk factors). Nasal suction may be useful in removing the mucus, especially before feeding the baby and nebulized hypertonic saline can offer relief.
A monthly injection with palivizumab, a monoclonal against the RSV F glycoprotein, during the RSV season prevents RSV-related hospital admission in children with congenital heart disease and preterm children with gestational age <= 35 weeks. In many countries, including the Netherlands, palivizumab is reimbursed only for children with gestational age <= 32 weeks because of high costs.
prognosis uitklapper, klik om te openen
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
Fortunately, the prognosis of children with RSV infection is favorable and death due to RSV infection is rare within developed countries. Children commonly experience severe coughing for up to six weeks after infection.
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .
RSV causes recurrent episodes of wheeze during the first years of life in about half of all children infected with RSV. Ongoing studies are investigating a link between asthma and RSV and the potential long term complications from RSV .